We serve Chemical Name:(+/-)-1-aminocyclopentane-cis-1,3-dicarboxylic acid CAS:39026-63-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(+/-)-1-aminocyclopentane-cis-1,3-dicarboxylic acid
CAS.NO:39026-63-6
Synonyms:MFCD00132879;cis-acpd;1-amino-cis-cyclopentane-1,3-dicarboxylic acid
Molecular Formula:C7H11NO4
Molecular Weight:173.16700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:352.7ºC at 760 mmHg
Density:1.452g/cm3
Index of Refraction:1.563
PSA:100.62000
Exact Mass:173.06900
LogP:0.35350
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00132879 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-amino-cis-cyclopentane-1,3-dicarboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00132879 Use and application,1-amino-cis-cyclopentane-1,3-dicarboxylic acid technical grade,usp/ep/jp grade.
Related News: From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. (+/-)-1-aminocyclopentane-cis-1,3-dicarboxylic acid manufacturer There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. (+/-)-1-aminocyclopentane-cis-1,3-dicarboxylic acid supplier There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. (+/-)-1-aminocyclopentane-cis-1,3-dicarboxylic acid vendor Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. (+/-)-1-aminocyclopentane-cis-1,3-dicarboxylic acid factory From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said.
